World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
29644
World Ranking
18987
National Ranking
9463

Overview

David R. Head is affiliated with Vanderbilt University Medical Center in the United States. Their research contributions span areas within medicine and biochemistry, genetics, and molecular biology, reflecting a multidisciplinary approach to biomedical science.

The primary fields of study in which David R. Head is active include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broader disciplines, their work is further categorized in specific subfields such as:

  • Hematology
  • Neurology
  • Molecular Biology

David R. Head's research addresses several scientific topics, with notable focus areas being:

  • Acute Myeloid Leukemia Research
  • Neuroblastoma Research and Treatments
  • Retinoids in leukemia and cellular processes

Their published work includes research papers published in respected venues, such as the American Journal of Hematology. A representative publication is:

  • Primary central nervous system erythroid sarcoma with NFIA-CBFA2T3 translocation: A rare but distinct clinicopathologic entity, 2020, American Journal of Hematology

In collaborative efforts, David R. Head frequently coauthors with a number of researchers, including:

  • Yevgeniy Linnik
  • Devang Pastakia
  • Ian L. Dryden
  • Emily F. Mason

Their academic output, though focused in specific niches, bridges clinical and molecular aspects of disease, integrating hematological malignancies with neurological and cellular research approaches.

Best Publications

  • Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Bruce D. Cheson;John M. Bennett;Kenneth J. Kopecky;Thomas Büchner

  • Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

    Marilyn L. Slovak;Kenneth J. Kopecky;Peter A. Cassileth;David H. Harrington

  • Age and acute myeloid leukemia

    Frederick R Appelbaum;Holly M Gundacker;David R Head;Marilyn L Slovak

  • Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

    Catherine P. Leith;Kenneth J. Kopecky;John Godwin;Thomas McConnell

  • Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

    B D Cheson;P A Cassileth;D R Head;C A Schiffer

  • Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

    Catherine P. Leith;Kenneth J. Kopecky;I-Ming Chen;Lisette Eijdems

  • Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

    C H Pui;R C Ribeiro;M L Hancock;G K Rivera

  • Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission

    Peter A. Cassileth;David P. Harrington;Frederick R. Appelbaum;Hillard M. Lazarus

  • A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study

    James K. Weick;Kenneth J. Kopecky;Frederick R. Appelbaum;David R. Head

  • Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.

    Alan F. List;Kenneth J. Kopecky;Cheryl L. Willman;David R. Head

  • A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases

    H Hasle;C M Niemeyer;J M Chessells;I Baumann

  • Methods to Detect P-Glycoprotein-associated Multidrug Resistance in Patients' Tumors: Consensus Recommendations

    William T. Beck;Thomas M. Grogan;Cheryl L. Willman;Carlos Cordon-Cardo

  • A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031)

    John E. Godwin;Kenneth J. Kopecky;David R. Head;Cheryl L. Willman

  • Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17).

    Jonathan D. Licht;Christine Chomienne;Andre Goy;Alex Chen

  • Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party

    D. Grimwade;A. Biondi;M.J. Mozziconacci;A. Hagemeijer

  • Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases.

    Ching Hon Pui;Lawrence S. Frankel;Andrew J. Carroll;Susana C. Raimondi

  • NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes

    Greenberg Pl;Attar E;Bennett Jm;Bloomfield Cd

  • Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.

    M Grever;K Kopecky;M K Foucar;D Head

  • Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases

    C. P. Leith;I-Ming Chen;K. J. Kopecky;F. R. Appelbaum

  • Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study

    W Crist;A Carroll;J Shuster;J Jackson

Frequent Co-Authors

Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
Frederick G. Behm
Frederick G. Behm University of Illinois at Chicago
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Cheryl L. Willman
Cheryl L. Willman University of New Mexico
Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
William M. Crist
William M. Crist University of Oklahoma
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
James R. Downing
James R. Downing St. Jude Children's Research Hospital
John M. Bennett
John M. Bennett University of Rochester Medical Center
Gaston K. Rivera
Gaston K. Rivera St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and related career paths in medicine can open doors to a range of opportunities in healthcare. For those looking to enter the workforce quickly, lpn fast track program options provide a streamlined route to becoming a licensed practical nurse, ideal for students eager to start their clinical experience.

If you’re interested in mental health, psych nurse practitioner programs allow you to pursue advanced practice roles with a focus on psychiatric and mental health care—often through flexible online formats.

For those drawn to management and leadership, pursuing an online healthcare administration degree can build the administrative and business skills needed in today’s healthcare settings.

Looking to advance even further? The cheapest mha programs offer graduates the expertise and credentials required for top-level roles—all while keeping education costs manageable.

Each of these online pathways provides flexible learning options and helps you shape a rewarding career in the healthcare sector.

Best Scientists Citing David R. Head

Trending Scientists